StockData
Genenta Science S.p.A. logo

Genenta Science S.p.A. (SAEN) bonds

SAENNasdaqBiological Products, (No Diagnostic Substances)Also trades as GNTA
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.62−0.06 (-8.24%)

Close on Nov 12, 2026Market cap $14.62MP/E –Yield –

Debt

Borrowings on the balance sheet, Dec 31, 2025

Genenta Science S.p.A. reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

Individual notes, bonds and loans

Genenta Science S.p.A.'s filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

See a number that looks wrong?